CLASS III Device recall · Reported 9 Jan 2013 · FDA Enforcement Report

Analyzing system consists of a small recalled by HemoCue AB

HemoCue AB is recalling Analyzing system consists of a small and portable analyzer and plastic microcuvettes, distributed in 17 states. The recall was initiated on 7 Nov 2012 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesSee serial numbers of affected devices in attachment profided by firm.
Quantity recalled48 affected analyzers

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0619-2013
FDA event ID
63825
Recalling firm
HemoCue AB, Angelholm, N/A
Classification
Class III
Status
Terminated
Recall initiated
7 Nov 2012
FDA classified
28 Dec 2012
Reported
9 Jan 2013
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Packaging Defects
Device type
Patient Monitors

Timeline

7 Nov 2012Recall initiated by company
28 Dec 2012Classified by FDA+51 days
9 Jan 2013Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Incorrect version of Quick Reference Guide (QRG) was delivered with products in shipment made from April1 st 2011 and onwards. In addition, a warranty statement was missing in the analyzer package.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Analyzing system consists of a small and portable analyzer and plastic microcuvettes. The microcuvette contains reagents deposited on its inner walls. The urine sample is drawn into the cavity by capillary action. The filled cuvette is inserted into the device where the contents of the cuvette are mixed through vibration. Within 90 seconds, the immunochemical reaction is completed and the turbidity is measured photometrically at 610 nm. The albumin concentration is proportional to the turbidity. When the end point is reached, the result is displayed in mg/L. The system can be used for the quantitative determination of low levels of albumin in urine for the purpose of screening for, diagnosing, monitoring and to supplement the clinical evidence in the treatment of microalbuminuria.

Where it was distributed

Distributed in the states of FL, MA, CA, OR, NY, NC, MO, ID, IN, KY, PA, TX, OK, IL, GA, KS, and UT.

CaliforniaFloridaGeorgiaIdahoIllinoisIndianaKansasKentuckyMassachusettsMissouriNorth CarolinaNew YorkOklahomaOregonPennsylvaniaTexasUtah

Questions about this recall

Why was it recalled?

Incorrect version of Quick Reference Guide (QRG) was delivered with products in shipment made from April1 st 2011 and onwards. In addition, a warranty statement was missing in the analyzer package.

Which lots are affected?

See serial numbers of affected devices in attachment profided by firm.

Where was it sold?

Distributed in the states of FL, MA, CA, OR, NY, NC, MO, ID, IN, KY, PA, TX, OK, IL, GA, KS, and UT.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from HemoCue AB

All 5

Other Patient Monitors recalls

All 1,022